CAPR Capricor Therapeutics: 5 Stock Signals & Tuesday Predicted Opening Price - Jul29 Advisory? 🚨
1 extracted signal · 1 resolved · 0 still active
StockInvest.us07 Jul 2026, 10:24 UTC
AI-generated source summary
Capricor Therapeutics (CAPR) is currently exhibiting a bearish trend, with multiple technical indicators suggesting a continued decline. The 3-month Moving Average Convergence Divergence (MACD) shows negative signals, and the stock is trading below both its 50-day and 200-day moving averages, which are at $167.08 and $152.36 respectively. This confluence indicates a bearish short-term and long-term forecast. The stock experienced a significant drop of 3.36% on the last trading day, closing at $22.43. The volume on this decline was 2 million shares, which is higher than the average volume, suggesting increased selling pressure. Fundamental analysis indicates a P/E ratio of -9.67 and a negative return on equity and assets, reinforcing the bearish outlook. The stock has also seen a significant decrease of 44.44% over the past 52 weeks. Analysts have also issued negative ratings, with multiple strong sell recommendations. The price is currently below key support and resistance levels, with the next resistance identified at $23.80 and no immediate support found. Given these factors, a further decline to a projected target of $20.43 is expected, with a failure bound at $24.05, which would invalidate the bearish short-term outlook.
AI-generated summary based on the source content.
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Source processing completed
Source analysis and structured extraction completed.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
Signals in this source
More Prediction Case Files from StockInvest.us
ONDS Ondas Inc. Stock Analysis: 5 Scenarios Before Q2 Call Aug 13, 2026 - Buy Signal or Crash? 🚀
SNDK Stock Jumped 26% — Buy Before Earnings or Wait for a Pullback?
META Stock Analysis: After 10% After-Hours Drop - Thursday Predicted Opening Price + 3 Scenarios 📉
VRT Vertiv: After Jul 29 Q2 Call & Crash - 5 Stock Signals + Thursday Predicted Opening Price? 📉
SNDK Sandisk: 3 Price Scenarios After 2,000% Rally & 7% Crash - Can 200% Returns Happen? 📈
Red Days for SNDK? Tuesday Premarket Hit + 2 Price Scenarios
StockInvest.us
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.